BMS & Pfizer Win Funding ‘Firsts’ In England For Migraine & Heart Disease Drugs

 
• By Neena Brizmohun

Bristol Myers Squibb and Pfizer both asked the health technology assessment body NICE to evaluate their respective drugs, Camzyos and Vydura, for use in indications that are narrower than those for which they are – or will potentially be – approved.

Camzyos and Vydura are to be made available on the NHS • Source: Shutterstock/inkdrop

More from Europe

More from Geography